The ZuoJinWan formula inhibits glycolysis of cisplatin resistant gastric cancer cells via p53 acetylation
Introduction: Gastric cancer is one of the common malignancies worldwide, and drug resistance is a major factor contributing to the difficulty of treatment in gastric cancer. Zuojinwan (ZJW) has been found to exhibit a certain inhibitory effect on tumor cells. However, the molecular mechanisms of ZJ...
Saved in:
Main Authors: | Zan Li (Author), Qiuxue Wu (Author), Zhenzhen Wei (Author), Yuli Zhang (Author), Bin Han (Author), Sailei Jia (Author), Hua Sui (Author), Qingfeng Tang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Extracts of Zuo Jin Wan, a traditional Chinese medicine, phenocopies 5-HTR1D antagonist in attenuating Wnt/β-catenin signaling in colorectal cancer cells
by: Jielu Pan, et al.
Published: (2017) -
Network pharmacology-based strategy to investigate pharmacological mechanisms of Zuojinwan for treatment of gastritis
by: Guohua Yu, et al.
Published: (2018) -
Network Pharmacology-Based Prediction and Verification of the Active Ingredients and Potential Targets of Zuojinwan for Treating Colorectal Cancer
by: Huang S, et al.
Published: (2020) -
Comment on "Sarcopenia and cardiovascular diseases: A systematic review and meta‐analysis" by Zuo et al.
by: Xiaoming Zhang, et al.
Published: (2023) -
Hotspots and Frontiers in Inflammatory Tumor Microenvironment Research: A Scientometric and Visualization Analysis
by: Yuli Zhang, et al.
Published: (2022)